They showed that blood lipids can be permanent COVID-19 biomarkers.

2024/03/26 Galarraga Aiestaran, Ana - Elhuyar Zientzia Iturria: Elhuyar aldizkaria

A study led by iCiQUS has shown that lipid in the blood can be biomarkers of permanent COVID-19. - Ed. Archive

Analyzing nearly 400 different lipids in plasma from 147 patients with permanent COVID-19, researchers at the CiQS center have been able to identify specific alterations and associate them with specific characteristics of permanent COVID-19, namely inflammation and permanent immune response. In addition, some of these lipids have confirmed their use as biomarkers.

Lipid techniques and artificial intelligence have been used for the research and researchers from other Spanish centers, including the UPV. The results, published openly in the Journal of Infection and Public Health, are fundamental to a better knowledge of sustainable COVID-19. In fact, most studies on COVID-19 have been conducted in the acute phase of the disease and persistent COVID-19 is still quite unknown, although it affects many people: between 10% and 20% of those infected do not heal completely and develop persistent symptoms.

The research now published therefore believes that it has contributed a great deal. Recently, the journal Science explained changes in blood proteins associated with permanent COVID-19. Researchers hope that these latest research will help to understand the mechanisms of permanent COVID-19, correctly diagnose them and develop personalized therapies.



Gai honi buruzko eduki gehiago

Elhuyarrek garatutako teknologia